---
title: "Gorgemead Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/71e5fb5e-ca5a-4019-bd02-d4d356958987
json: https://whiteintel.dev/api/public/dossier/71e5fb5e-ca5a-4019-bd02-d4d356958987
identifier: psc:MiiujL4kOEDD-oI8IRu99s_3_Ho
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Gorgemead Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:MiiujL4kOEDD-oI8IRu99s_3_Ho`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/71e5fb5e-ca5a-4019-bd02-d4d356958987  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/71e5fb5e-ca5a-4019-bd02-d4d356958987  

## Ownership & control

### Holdings / subsidiaries

- **NASH DRUG COMPANY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2924e1ac-9742-50fe-a551-4ccc4b008244

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Gorgemead Limited**. Human view: https://whiteintel.dev/entity/71e5fb5e-ca5a-4019-bd02-d4d356958987 · Structured JSON: https://whiteintel.dev/api/public/dossier/71e5fb5e-ca5a-4019-bd02-d4d356958987._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._